I agree that this site is using cookies. You can find further informations here.
X
Oger, Joel
136  results:
Search for persons X
?
1

A real-life experience of serological diagnosis of myasthen..:

Oger, Joel ; Kumar, Pankaj ; Mousavi, Ali...
Journal of the Neurological Sciences.  455 (2023)  - p. 122023 , 2023
Link: https://doi.org/10.1016/..
 
?
2

To measure musk ABS in ACHR AB negative sera: RIPA is more ..:

Frykman, Hans ; Oger, Joel ; Gibbs, Ebrima..
Journal of the Neurological Sciences.  429 (2021)  - p. 118853 , 2021
Link: https://doi.org/10.1016/..
 
?
3

Immunopathology of Autoimmune Myasthenia Gravis: Implicatio..:

Frykman, Hans ; Kumar, Pankaj ; Oger, Joel
Frontiers in Neurology.  11 (2020)  - p. , 2020
Link: https://doi.org/10.3389/..
 
?
4

Epidemiological evidence for a hereditary contribution to m..:

Green, Joshua D ; Barohn, Richard J ; Bartoccion, Emanuela...
BMJ Open.  10 (2020)  9 - p. e037909 , 2020
Link: https://doi.org/10.1136/..
 
?
5

Minimal manifestation status and prednisone withdrawal in t..:

Lee, Ikjae ; Kuo, Hui-Chien ; Aban, Inmaculada B....
Neurology.  95 (2020)  6 - p. , 2020
Link: https://doi.org/10.1212/..
 
?
6

Multiple sclerosis: effect of beta interferon treatment on ..:

Kingwell, Elaine ; Leray, Emmanuelle ; Zhu, Feng...
Brain.  142 (2019)  5 - p. 1324-1333 , 2019
Link: https://doi.org/10.1093/..
 
?
7

Predictive validity of NEDA in the 16- and 21-year follow-u..:

Goodin, Douglas S ; Reder, Anthony T ; Traboulsee, Anthony L...
Multiple Sclerosis Journal.  25 (2018)  6 - p. 837-847 , 2018
Link: https://doi.org/10.1177/..
 
?
8

Disability progression in aggressive multiple sclerosis:

Menon, Suresh ; Zhu, Feng ; Shirani, Afsaneh...
Multiple Sclerosis Journal.  23 (2016)  3 - p. 456-463 , 2016
Link: https://doi.org/10.1177/..
 
?
9

Association between the use of selective serotonin reuptake..:

Zhang, Tingting ; Kingwell, Elaine ; De Jong, Hilda JI...
Pharmacoepidemiology and Drug Safety.  25 (2016)  10 - p. 1150-1159 , 2016
Link: https://doi.org/10.1002/..
 
?
10

Treatment of Myasthenia Gravis in the Aged:

Alkhawajah, Nuha M. ; Oger, Joel
Drugs & Aging.  32 (2015)  9 - p. 689-697 , 2015
Link: https://doi.org/10.1007/..
 
?
11

Antibody dissociation rates are predictive of neutralizing ..:

Gibbs, Ebrima ; Karim, Mohammad Ehsanul ; Oger, Joel
Clinical Immunology.  157 (2015)  1 - p. 91-101 , 2015
Link: https://doi.org/10.1016/..
 
?
12

An update on laboratory diagnosis in myasthenia gravis:

Oger, Joel ; Frykman, Hans
Clinica Chimica Acta.  444 (2015)  - p. 126-131 , 2015
Link: https://doi.org/10.1016/..
 
?
13

Serum proteomics in multiple sclerosis disease progression:

Tremlett, Helen ; Dai, Darlene L.Y. ; Hollander, Zsuzsanna...
Journal of Proteomics.  118 (2015)  - p. 2-11 , 2015
Link: https://doi.org/10.1016/..
 
?
14

Multiple Sclerosis in Older Adults: The Clinical Profile an..:

Shirani, Afsaneh ; Zhao, Yinshan ; Petkau, John...
BioMed Research International.  2015 (2015)  - p. 1-11 , 2015
Link: https://doi.org/10.1155/..
 
?
15

A longitudinal model for disease progression was developed ..:

Lawton, Michael ; Tilling, Kate ; Robertson, Neil...
Journal of Clinical Epidemiology.  68 (2015)  11 - p. 1355-1365 , 2015
Link: https://doi.org/10.1016/..
 
1-15